$4.28
0[0.00%]
At close: Apr 17
$4.28
0[0.00%]
PreMarket: 4:00PM EDT
G1 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of G1 Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | AM | GTHX | Q1 | -$0.53 | -$0.22 | — | — | $12.95M | $15.07M | — | — | Get Alert |
02/28/2024 | AM | GTHX | Q4 | -$0.73 | -$0.27 | -$0.21 | 22.22% | $10.25M | $13.07M | $14.87M | 13.79% | Get Alert |
11/01/2023 | AM | GTHX | Q3 | -$0.59 | -$0.33 | -$0.35 | -6.06% | $23.58M | $14.23M | $12.30M | -13.56% | Get Alert |
08/02/2023 | AM | GTHX | Q2 | -$0.92 | -$0.17 | $0.14 | 182.35% | $10.57M | $28.34M | $42.39M | 49.58% | Get Alert |
05/03/2023 | AM | GTHX | Q1 | -$1.15 | -$0.64 | -$0.53 | 17.19% | $6.90M | $11.19M | $12.95M | 15.69% | Get Alert |
03/01/2023 | AM | GTHX | Q4 | -$0.94 | -$0.84 | -$0.73 | 13.10% | $5.80M | $9.65M | $10.25M | 6.22% | Get Alert |
11/02/2022 | AM | GTHX | Q3 | -$1.00 | -$0.63 | -$0.59 | 6.35% | $4.86M | $23.27M | $23.58M | 1.31% | Get Alert |
08/03/2022 | AM | GTHX | Q2 | -$0.94 | -$1.02 | -$0.92 | 9.80% | $6.60M | $9.14M | $10.57M | 15.68% | Get Alert |
05/04/2022 | AM | GTHX | Q1 | -$0.65 | -$0.97 | -$1.15 | -18.56% | $14.22M | $6.69M | $6.90M | 3.17% | Get Alert |
02/23/2022 | AM | GTHX | Q4 | -$0.67 | -$1.03 | -$0.94 | 8.74% | $16.55M | $5.68M | $5.80M | 2.04% | Get Alert |
11/03/2021 | AM | GTHX | Q3 | -$0.31 | -$1.00 | -$1.00 | 0.00% | $26.60M | $5.18M | $4.86M | -6.22% | Get Alert |
08/04/2021 | PM | GTHX | Q2 | -$0.83 | -$0.97 | -$0.94 | 3.09% | $2.14M | $2.59M | $6.60M | 154.98% | Get Alert |
05/05/2021 | PM | GTHX | Q1 | -$0.82 | -$1.07 | -$0.65 | 39.25% | $0.00 | $770.00K | $14.22M | 1746.49% | Get Alert |
02/24/2021 | PM | GTHX | Q4 | -$0.94 | -$0.87 | -$0.67 | 22.99% | $0.00 | $4.06M | $16.55M | 307.54% | Get Alert |
11/04/2020 | PM | GTHX | Q3 | -$0.86 | -$0.30 | -$0.31 | -3.33% | $0.00 | $28.57M | $26.60M | -6.90% | Get Alert |
08/05/2020 | PM | GTHX | Q2 | -$0.82 | -$0.83 | -$0.83 | 0.00% | $0.00 | $2.25M | $2.14M | -4.89% | Get Alert |
05/06/2020 | PM | GTHX | Q1 | -$0.64 | -$0.98 | -$0.82 | 16.33% | $0.00 | — | $0.00 | — | Get Alert |
02/26/2020 | PM | GTHX | Q4 | -$0.65 | -$0.96 | -$0.94 | 2.08% | $0.00 | — | $0.00 | — | Get Alert |
11/05/2019 | PM | GTHX | Q3 | -$0.59 | — | -$0.86 | — | $0.00 | — | $0.00 | — | Get Alert |
G1 Therapeutics (GTHX) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.21, which beat the estimate of $-0.27.
The Actual Revenue was $14.9M, which beat the estimate of $13.1M.
Browse earnings estimates, EPS, and revenue on all stocks.